Cortexyme, Inc. (CRTX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 12.05 |
| Open | 11.72 |
| Bid | 0.00 x 1000 |
| Ask | 10.60 x 800 |
| Day's Range | 11.35 - 11.94 |
| 52 Week Range | 10.15 - 121.98 |
| Volume | |
| Avg. Volume | 2,359,425 |
| Market Cap | 319.093M |
| Beta (5Y Monthly) | 0.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.94 |
| Earnings Date | Oct 29, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 64.57 |
- Motley Fool
Why Cortexyme Stock Imploded in 2021
The clinical-stage drugmaker's shares imploded last year in response to the failure of its lead Alzheimer's disease candidate atuzaginstat in a combined phase 2/3 study. Specifically, atuzaginstat reportedly missed both of its co-primary endpoints in the phase 2/3 Gain trial as a treatment for mild to moderate forms of Alzheimer's disease. Since announcing these disappointing trial results late last year, Cortexyme has said that it plans to trial the drug yet again.
- InvestorPlace
3 Most-Shorted Stocks at 52-Week Lows to Buy
Has Wall Street gotten ahead of itself? Depending on where one looks, it’s a fair enough question these days. But that certainly doesn’t include the market’s most-shorted stocks. Let’s take a look both off and on the price charts of three of last year’s heavily-shorted stocks at 52-week lows, which today are better-equipped to usher in a much happier 2022 for bullish investors. The start to the new year has been filled with highs and lows for index investors. After striking record breaking price
- Simply Wall St.
Do Institutions Own Cortexyme, Inc. (NASDAQ:CRTX) Shares?
If you want to know who really controls Cortexyme, Inc. ( NASDAQ:CRTX ), then you'll have to look at the makeup of its...
